Healthcare (SH:603313) Shang Hai Zheng Quan Bao·2026-02-04 19:04Core Viewpoint - The company has provided a guarantee of 80 million RMB for its subsidiary Jiangsu Ligao to secure a credit line from Xiamen International Bank, which is part of a broader strategy to support the subsidiary's business development needs and operational requirements [1][2]. Group 1: Guarantee Details - The total credit line applied by Jiangsu Ligao is 80 million RMB, and the company has signed a guarantee contract with Xiamen International Bank for this amount [1]. - Prior to this guarantee, the company had no existing guarantees for Jiangsu Ligao, and the remaining available guarantee limit after this transaction is 220 million RMB [2]. - The guarantee is a joint liability guarantee, covering all principal debts, interest, penalties, and related costs associated with the financing [5]. Group 2: Internal Decision-Making Process - The guarantee was approved during the company's board meeting on April 24, 2025, and subsequently ratified at the annual shareholders' meeting on May 16, 2025, which set a total guarantee limit of 300 million RMB for the year [1][6]. - The company holds a 90% stake in Jiangsu Ligao, allowing it to effectively control the subsidiary's operations and financial health [5]. Group 3: Necessity and Reasonableness of the Guarantee - The guarantee is deemed necessary and reasonable as Jiangsu Ligao currently has no overdue debts and poses no repayment risk, aiming to expand its financing channels for operational needs [5]. - The company will continue to monitor the loan usage and repayment status of Jiangsu Ligao to mitigate any potential risks associated with the guarantee [5]. Group 4: Overall Guarantee Situation - As of the announcement date, the total external guarantees provided by the company and its subsidiaries amount to approximately 3.7 billion RMB, which represents 101.85% of the company's latest audited net assets, with no overdue guarantees reported [6][7].